| Antiviral | EC50 ratio | Phenotype | Strain | Source | Marker | Assay | Reference |
|---|---|---|---|---|---|---|---|
| Letermovir | 2.00 | Low level resistance | Clinical Isolate | Details | Phenotypes of cytomegalovirus genetic variants encountered in a letermovir clinical trial illustrate the importance of genotyping validation. (Aug 2024) |
| Mutant | Resistances |
|---|---|
| S229F |
Letermovir:
|